HEADER TRANSFERASE 30-JUN-15 5A6N TITLE CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) TITLE 2 IN COMPLEX WITH COMPOUND 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEATH-ASSOCIATED PROTEIN KINASE 3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN, UNP RESIDUES 9-289; COMPND 5 SYNONYM: DAP KINASE 3, DAP-LIKE KINASE, DLK, MYPT1 KINASE, ZIPPER- COMPND 6 INTERACTING PROTEIN KINASE, ZIP-KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS TRANSFERASE, DAPK3, HUMAN DEATH ASSOCIATED PROTEIN KINASE 3, DAP-LIKE KEYWDS 2 KINASE, DLK, ZIPPER-INTERACTING PROTEIN KINASE, ZIP-KINASE EXPDTA X-RAY DIFFRACTION AUTHOR T.RODRIGUES,D.REKER,M.WELIN,M.CALDERA,C.BRUNNER,G.GABERNET, AUTHOR 2 P.SCHNEIDER,B.WALSE,G.SCHNEIDER REVDAT 4 10-JAN-24 5A6N 1 REMARK REVDAT 3 27-JAN-16 5A6N 1 JRNL REVDAT 2 04-NOV-15 5A6N 1 JRNL REVDAT 1 21-OCT-15 5A6N 0 JRNL AUTH T.RODRIGUES,D.REKER,M.WELIN,M.CALDERA,C.BRUNNER,G.GABERNET, JRNL AUTH 2 P.SCHNEIDER,B.WALSE,G.SCHNEIDER JRNL TITL DE NOVO FRAGMENT DESIGN FOR DRUG DISCOVERY AND CHEMICAL JRNL TITL 2 BIOLOGY. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 54 15079 2015 JRNL REFN ISSN 1433-7851 JRNL PMID 26486226 JRNL DOI 10.1002/ANIE.201508055 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 67990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 3449 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4886 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.38 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE SET COUNT : 270 REMARK 3 BIN FREE R VALUE : 0.2610 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4359 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 298 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.19000 REMARK 3 B22 (A**2) : -0.05000 REMARK 3 B33 (A**2) : 0.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.098 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.097 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.875 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4511 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4411 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6076 ; 1.512 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10173 ; 1.153 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 545 ; 5.434 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 217 ;36.335 ;24.147 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 854 ;13.275 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;19.043 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 677 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4995 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1016 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2165 ; 1.940 ; 2.348 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2164 ; 1.935 ; 2.346 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2707 ; 2.931 ; 3.511 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2346 ; 2.869 ; 2.785 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUE REFINED INDIVIDUALLY. RESIDUES 170-174 IN REMARK 3 CHAIN B ARE DISORDERED. REMARK 4 REMARK 4 5A6N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1290064215. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 71490 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 29.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3BHY REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23% PROPANEDIOL, 0.1M NA/K PHOSPHATE REMARK 280 PH 6.2, 10% GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.36300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.65050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.88750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.65050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.36300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.88750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 7 REMARK 465 ARG A 279 REMARK 465 ARG A 280 REMARK 465 ARG A 281 REMARK 465 ASN A 282 REMARK 465 VAL A 283 REMARK 465 ARG A 284 REMARK 465 GLY A 285 REMARK 465 GLU A 286 REMARK 465 ASP A 287 REMARK 465 SER A 288 REMARK 465 GLY A 289 REMARK 465 ALA B 170 REMARK 465 GLY B 171 REMARK 465 ASN B 172 REMARK 465 GLU B 173 REMARK 465 PHE B 174 REMARK 465 ARG B 279 REMARK 465 ARG B 280 REMARK 465 ARG B 281 REMARK 465 ASN B 282 REMARK 465 VAL B 283 REMARK 465 ARG B 284 REMARK 465 GLY B 285 REMARK 465 GLU B 286 REMARK 465 ASP B 287 REMARK 465 SER B 288 REMARK 465 GLY B 289 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 100 O HOH B 2046 2.05 REMARK 500 O HOH A 2049 O HOH A 2050 2.15 REMARK 500 O ALA B 106 O HOH B 2053 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 48 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 63 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG A 63 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ASP A 139 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG B 63 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ARG B 63 NE - CZ - NH2 ANGL. DEV. = -5.3 DEGREES REMARK 500 ASP B 235 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 85 -161.25 -111.50 REMARK 500 PHE A 138 -2.71 71.56 REMARK 500 ASP A 139 49.65 -141.82 REMARK 500 ASP A 161 84.49 70.79 REMARK 500 PHE A 236 59.31 -113.20 REMARK 500 ASN B 85 -165.87 -119.30 REMARK 500 PHE B 138 -0.62 72.39 REMARK 500 ASP B 139 41.20 -140.45 REMARK 500 ASN B 151 31.29 -94.63 REMARK 500 ASP B 161 82.34 71.07 REMARK 500 ASN B 176 -11.25 78.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2025 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH B2017 DISTANCE = 6.11 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE U7E A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5A6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE APO FORM OF THE UNPHOSPHORYLATED HUMAN REMARK 900 DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) DBREF 5A6N A 9 289 UNP O43293 DAPK3_HUMAN 9 289 DBREF 5A6N B 9 289 UNP O43293 DAPK3_HUMAN 9 289 SEQADV 5A6N SER A 7 UNP O43293 EXPRESSION TAG SEQADV 5A6N MET A 8 UNP O43293 EXPRESSION TAG SEQADV 5A6N SER B 7 UNP O43293 EXPRESSION TAG SEQADV 5A6N MET B 8 UNP O43293 EXPRESSION TAG SEQRES 1 A 283 SER MET VAL GLU ASP HIS TYR GLU MET GLY GLU GLU LEU SEQRES 2 A 283 GLY SER GLY GLN PHE ALA ILE VAL ARG LYS CYS ARG GLN SEQRES 3 A 283 LYS GLY THR GLY LYS GLU TYR ALA ALA LYS PHE ILE LYS SEQRES 4 A 283 LYS ARG ARG LEU SER SER SER ARG ARG GLY VAL SER ARG SEQRES 5 A 283 GLU GLU ILE GLU ARG GLU VAL ASN ILE LEU ARG GLU ILE SEQRES 6 A 283 ARG HIS PRO ASN ILE ILE THR LEU HIS ASP ILE PHE GLU SEQRES 7 A 283 ASN LYS THR ASP VAL VAL LEU ILE LEU GLU LEU VAL SER SEQRES 8 A 283 GLY GLY GLU LEU PHE ASP PHE LEU ALA GLU LYS GLU SER SEQRES 9 A 283 LEU THR GLU ASP GLU ALA THR GLN PHE LEU LYS GLN ILE SEQRES 10 A 283 LEU ASP GLY VAL HIS TYR LEU HIS SER LYS ARG ILE ALA SEQRES 11 A 283 HIS PHE ASP LEU LYS PRO GLU ASN ILE MET LEU LEU ASP SEQRES 12 A 283 LYS ASN VAL PRO ASN PRO ARG ILE LYS LEU ILE ASP PHE SEQRES 13 A 283 GLY ILE ALA HIS LYS ILE GLU ALA GLY ASN GLU PHE LYS SEQRES 14 A 283 ASN ILE PHE GLY THR PRO GLU PHE VAL ALA PRO GLU ILE SEQRES 15 A 283 VAL ASN TYR GLU PRO LEU GLY LEU GLU ALA ASP MET TRP SEQRES 16 A 283 SER ILE GLY VAL ILE THR TYR ILE LEU LEU SER GLY ALA SEQRES 17 A 283 SER PRO PHE LEU GLY GLU THR LYS GLN GLU THR LEU THR SEQRES 18 A 283 ASN ILE SER ALA VAL ASN TYR ASP PHE ASP GLU GLU TYR SEQRES 19 A 283 PHE SER ASN THR SER GLU LEU ALA LYS ASP PHE ILE ARG SEQRES 20 A 283 ARG LEU LEU VAL LYS ASP PRO LYS ARG ARG MET THR ILE SEQRES 21 A 283 ALA GLN SER LEU GLU HIS SER TRP ILE LYS ALA ILE ARG SEQRES 22 A 283 ARG ARG ASN VAL ARG GLY GLU ASP SER GLY SEQRES 1 B 283 SER MET VAL GLU ASP HIS TYR GLU MET GLY GLU GLU LEU SEQRES 2 B 283 GLY SER GLY GLN PHE ALA ILE VAL ARG LYS CYS ARG GLN SEQRES 3 B 283 LYS GLY THR GLY LYS GLU TYR ALA ALA LYS PHE ILE LYS SEQRES 4 B 283 LYS ARG ARG LEU SER SER SER ARG ARG GLY VAL SER ARG SEQRES 5 B 283 GLU GLU ILE GLU ARG GLU VAL ASN ILE LEU ARG GLU ILE SEQRES 6 B 283 ARG HIS PRO ASN ILE ILE THR LEU HIS ASP ILE PHE GLU SEQRES 7 B 283 ASN LYS THR ASP VAL VAL LEU ILE LEU GLU LEU VAL SER SEQRES 8 B 283 GLY GLY GLU LEU PHE ASP PHE LEU ALA GLU LYS GLU SER SEQRES 9 B 283 LEU THR GLU ASP GLU ALA THR GLN PHE LEU LYS GLN ILE SEQRES 10 B 283 LEU ASP GLY VAL HIS TYR LEU HIS SER LYS ARG ILE ALA SEQRES 11 B 283 HIS PHE ASP LEU LYS PRO GLU ASN ILE MET LEU LEU ASP SEQRES 12 B 283 LYS ASN VAL PRO ASN PRO ARG ILE LYS LEU ILE ASP PHE SEQRES 13 B 283 GLY ILE ALA HIS LYS ILE GLU ALA GLY ASN GLU PHE LYS SEQRES 14 B 283 ASN ILE PHE GLY THR PRO GLU PHE VAL ALA PRO GLU ILE SEQRES 15 B 283 VAL ASN TYR GLU PRO LEU GLY LEU GLU ALA ASP MET TRP SEQRES 16 B 283 SER ILE GLY VAL ILE THR TYR ILE LEU LEU SER GLY ALA SEQRES 17 B 283 SER PRO PHE LEU GLY GLU THR LYS GLN GLU THR LEU THR SEQRES 18 B 283 ASN ILE SER ALA VAL ASN TYR ASP PHE ASP GLU GLU TYR SEQRES 19 B 283 PHE SER ASN THR SER GLU LEU ALA LYS ASP PHE ILE ARG SEQRES 20 B 283 ARG LEU LEU VAL LYS ASP PRO LYS ARG ARG MET THR ILE SEQRES 21 B 283 ALA GLN SER LEU GLU HIS SER TRP ILE LYS ALA ILE ARG SEQRES 22 B 283 ARG ARG ASN VAL ARG GLY GLU ASP SER GLY HET U7E A 300 15 HET GOL A 301 6 HET PGO A 302 5 HET PGO A 303 5 HET GOL B 301 6 HETNAM U7E 5-(3-SULFAMOYLPHENYL)-1H-1,2,3,4-TETRAZOL-1-IDE HETNAM GOL GLYCEROL HETNAM PGO S-1,2-PROPANEDIOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 U7E C7 H7 N5 O2 S FORMUL 4 GOL 2(C3 H8 O3) FORMUL 5 PGO 2(C3 H8 O2) FORMUL 8 HOH *298(H2 O) HELIX 1 1 MET A 8 ASP A 11 5 4 HELIX 2 2 SER A 57 ILE A 71 1 15 HELIX 3 3 GLU A 100 ALA A 106 1 7 HELIX 4 4 THR A 112 LYS A 133 1 22 HELIX 5 5 LYS A 141 GLU A 143 5 3 HELIX 6 6 ALA A 170 ASN A 176 1 7 HELIX 7 7 ILE A 177 GLY A 179 5 3 HELIX 8 8 ALA A 185 ASN A 190 1 6 HELIX 9 9 LEU A 196 GLY A 213 1 18 HELIX 10 10 THR A 221 VAL A 232 1 12 HELIX 11 11 ASP A 237 SER A 242 1 6 HELIX 12 12 SER A 245 ARG A 254 1 10 HELIX 13 13 ASP A 259 ARG A 263 5 5 HELIX 14 14 THR A 265 HIS A 272 1 8 HELIX 15 15 HIS A 272 ALA A 277 1 6 HELIX 16 16 MET B 8 HIS B 12 1 5 HELIX 17 17 SER B 57 ILE B 71 1 15 HELIX 18 18 GLU B 100 GLU B 107 1 8 HELIX 19 19 THR B 112 LYS B 133 1 22 HELIX 20 20 LYS B 141 GLU B 143 5 3 HELIX 21 21 ALA B 185 ASN B 190 1 6 HELIX 22 22 LEU B 196 GLY B 213 1 18 HELIX 23 23 THR B 221 VAL B 232 1 12 HELIX 24 24 SER B 245 LEU B 256 1 12 HELIX 25 25 ASP B 259 ARG B 263 5 5 HELIX 26 26 THR B 265 HIS B 272 1 8 HELIX 27 27 HIS B 272 ALA B 277 1 6 SHEET 1 AA 5 TYR A 13 GLY A 22 0 SHEET 2 AA 5 ALA A 25 GLN A 32 -1 O ALA A 25 N GLY A 22 SHEET 3 AA 5 GLU A 38 LYS A 45 -1 O TYR A 39 N CYS A 30 SHEET 4 AA 5 ASP A 88 GLU A 94 -1 O VAL A 89 N ILE A 44 SHEET 5 AA 5 LEU A 79 GLU A 84 -1 N HIS A 80 O ILE A 92 SHEET 1 AB 2 ILE A 135 ALA A 136 0 SHEET 2 AB 2 HIS A 166 LYS A 167 -1 O HIS A 166 N ALA A 136 SHEET 1 AC 2 ILE A 145 LEU A 147 0 SHEET 2 AC 2 ILE A 157 LEU A 159 -1 O LYS A 158 N MET A 146 SHEET 1 BA 5 TYR B 13 GLY B 22 0 SHEET 2 BA 5 ALA B 25 GLN B 32 -1 O ALA B 25 N GLY B 22 SHEET 3 BA 5 GLU B 38 LYS B 45 -1 O TYR B 39 N CYS B 30 SHEET 4 BA 5 ASP B 88 GLU B 94 -1 O VAL B 89 N ILE B 44 SHEET 5 BA 5 LEU B 79 GLU B 84 -1 N HIS B 80 O ILE B 92 SHEET 1 BB 2 ILE B 135 ALA B 136 0 SHEET 2 BB 2 HIS B 166 LYS B 167 -1 O HIS B 166 N ALA B 136 SHEET 1 BC 2 ILE B 145 LEU B 147 0 SHEET 2 BC 2 ILE B 157 LEU B 159 -1 O LYS B 158 N MET B 146 SITE 1 AC1 7 GLY A 20 LYS A 42 ILE A 77 ASP A 161 SITE 2 AC1 7 HOH A2039 HOH A2104 HOH A2183 SITE 1 AC2 8 GLU A 100 ASP A 103 HIS B 73 PRO B 74 SITE 2 AC2 8 ILE B 76 THR B 78 LYS B 158 HOH B2037 SITE 1 AC3 3 TYR A 234 ASP A 235 ARG A 253 SITE 1 AC4 2 ILE A 209 LEU A 210 SITE 1 AC5 7 LYS B 42 GLU B 64 ILE B 77 ILE B 160 SITE 2 AC5 7 ASP B 161 PHE B 162 HOH B2115 CRYST1 80.726 87.775 91.301 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012388 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011393 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010953 0.00000 MTRIX1 1 -0.998000 0.049000 -0.043000 20.29100 1 MTRIX2 1 0.040000 -0.043000 -0.998000 251.39300 1 MTRIX3 1 -0.051000 -0.988000 0.041000 241.35200 1